Future work with ovarian cancer cell lines will need to address the question of whether or not SEC62 overexpression is associated with increased ER stress tolerance as well as increased migratory and invasive potential, three hallmarks of cancer that had been observed for various other SEC62 overexpressing tumor cells (reviewed in this Research Topic by Zimmermann et al., 2022). The gene discussed is SEC62; the disease is ovarian carcinoma.